
Currently out of the existing stock ratings of Adam Ron, 6 are a HOLD (46.15%), 7 are a BUY (53.85%).
Analyst Adam Ron, currently employed at BAML, has had 87.5% of price targets met with an average potential upside of 20.55%, reached in 220 days on average.
Adam Ron has documented 26 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALHC, Alignment Healthcare LLC at 03-Mar-2025.
Analyst best performing recommendations are on OSCR (OSCAR HEALTH).
The best stock recommendation documented was for OSCR (OSCAR HEALTH) on 11/6/2024. The price target of $13.5 was fulfilled within 7 days with a profit of $2.05 (13.18%), with a performance score of 18.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-Apr-2023
$55
$44
2 years 9 months ago
(22-Feb-2024)
1/2 (50%)
$13.3 (31.89%)
323
Buy Since 17-Oct-2023
$45
$45
2 years 9 months 23 days ago
(30-Jan-2024)
3/3 (100%)
$8.94 (24.79%)
75
Buy Since 19-Dec-2022
$60
$40
3 years 8 months 26 days ago
(27-Feb-2023)
1/2 (50%)
$24.75 (70.21%)
115
Hold Since 12-Aug-2021
$57
$50
4 years 3 months 14 days ago
(08-Aug-2022)
2/3 (66.67%)
$4.05 (7.65%)
28
Buy Since 26-Apr-2018
$75
$27.5
5 years 4 months 29 days ago
(24-Jun-2021)
3/3 (100%)
$14.89 (24.77%)
335
What Year was the first public recommendation made by Adam Ron?